The Royal College of Ophthalmologists is calling for applications for membership of the new national Age Related Macular Degeneration (AMD) Audit Advisory Group.
As an Advisory Group member, you will support the Clinical Lead, Martin McKibbin and project manager, Lynne Sanders, in developing the national AMD audit. The Advisory Group will work in partnership with the RCOphth NOD delivery team and key stakeholders to agree clinical and process outcomes for the audit, suggest re-design of patient pathways and identify opportunities to publish the audit results widely to raise the profile of the AMD Audit.
Applicants should have prior experience and expertise in both clinical audit and treatment of neovascular AMD and be members of the Royal College of Ophthalmologists.
AMD is estimated to affect 600,000 in the UK, with an estimated 39,800 new patients developing the “wet” or neovascular form of AMD each year. Prompt and continued treatment is required to maintain or improve visual function. Late presentation, delayed treatment and poor compliance with planned treatment may lead to sight impairment and loss of independent living. As the incidence of late AMD is predicted to rise by almost 60% by 2035, there is a need to identify and disseminate best practice through a national audit.
Please see the AMD Audit Advisory Terms of Reference outlining the full role description and send your AMD Advisory Group Application Form to [email protected]. Deadline for applications are 17:00 on Monday 02 November 2020, with interviews expected to be held in late November 2020.
If you would like more information, please contact the RCOphth NOD Project Team on [email protected].